Development of an automated immunoassay for NT-proBNP on the Dade Behring Dimension® clinical chemistry system

被引:0
|
作者
Wei, T [1 ]
Tuhy, P [1 ]
Bantum, L [1 ]
Posey, A [1 ]
Miller, L [1 ]
Singh, P [1 ]
Duffy, J [1 ]
Pierson-Perry, J [1 ]
机构
[1] Dade Behring Inc, Newark, DE USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:A13 / A14
页数:2
相关论文
共 50 条
  • [41] A chemiluminescence immunoassay for the detection of NT-proBNP
    Chen, Yu-Yan
    Li, Shu-Lian
    Lin, Hui-Ling
    Li, Wen-Dong
    Zhu, Xiao-Zhen
    Zhang, Hui-Lin
    ANALYTICAL BIOCHEMISTRY, 2020, 611
  • [42] Clinical concordance for exclusion of acute heart failure using the RAMP and dade dimension RxL NT-proBNP assays
    Offner, M.
    Winckel, E.
    Jung, A.
    Lamy, T.
    Arthur, G.
    Zucker, M. L.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A10 - A10
  • [43] Performance of a CK-MB assay for the Dade Behring Dimension® RxL clinical chemistry system.
    Rossi, R
    Demers, L
    Walsh, P
    Pessin-Minsley, M
    Buckley, P
    Fisher, G
    CLINICAL CHEMISTRY, 1998, 44 : A125 - A125
  • [44] Development of a fully automated tacrolimus immunoassay for the Dimension® clinical chemistry system.
    Wei, T
    Parker, G
    Wang, C
    CLINICAL CHEMISTRY, 2001, 47 (06) : A75 - A75
  • [45] Evaluation of an automated, no pre-treatment hemoglobin A1c assay on the Dade Behring Dimension® clinical chemistry system.
    Terrell, AR
    Hock, KG
    Ruttle, D
    Cervelli, DR
    Scott, MG
    CLINICAL CHEMISTRY, 2002, 48 (06) : A37 - A38
  • [46] Performance of EMITT® based drugs of abuse methods on the Dade Behring Dimension® clinical chemistry system.
    Siefring, GE
    Gorzynski, TJ
    Masulli, IS
    Fleming, MS
    CLINICAL CHEMISTRY, 2000, 46 (06) : A196 - A196
  • [47] Development of NT-proBNP, Troponin, TSH, and FT4 LOCI® assays on the new Dimension® EXL™ with LM clinical chemistry system
    Snyder, J. T.
    Benson, C. M.
    Briggs, C.
    Duggan, L.
    Gilbert, E. R.
    Nichols, P. A.
    Privon, G. A.
    Vickery, D. K.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A92 - A92
  • [48] Development and analytical performance of an improved method for cardiac troponin-I on the Dade Behring Dimension® clinical chemistry system.
    Kaminski, D
    Sivakoff, S
    McCormack, B
    Pierson-Perry, J
    CLINICAL CHEMISTRY, 2001, 47 (06) : A211 - A212
  • [49] Evaluation of a new heterogeneous immunoassay for the whole-blood determination of cyclosporin on the dade Behring dimension RXL clinical chemistry analyzer
    Morand, K
    Huet, E
    Blanchet, B
    Astier, A
    Hulin, A
    ANNALES DE BIOLOGIE CLINIQUE, 2003, 61 (06) : 713 - 718
  • [50] An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the dade-behring dimension RxL max clinical chemistry system
    Mendu, Damodara Rao
    Chou, Peter P.
    Soldin, Steven J.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (05) : 632 - 637